Accessory pathway analysis using a multimodal deep learning model.

Journal: Scientific reports
Published Date:

Abstract

Cardiac accessory pathways (APs) in Wolff-Parkinson-White (WPW) syndrome are conventionally diagnosed with decision tree algorithms; however, there are problems with clinical usage. We assessed the efficacy of the artificial intelligence model using electrocardiography (ECG) and chest X-rays to identify the location of APs. We retrospectively used ECG and chest X-rays to analyse 206 patients with WPW syndrome. Each AP location was defined by an electrophysiological study and divided into four classifications. We developed a deep learning model to classify AP locations and compared the accuracy with that of conventional algorithms. Moreover, 1519 chest X-ray samples from other datasets were used for prior learning, and the combined chest X-ray image and ECG data were put into the previous model to evaluate whether the accuracy improved. The convolutional neural network (CNN) model using ECG data was significantly more accurate than the conventional tree algorithm. In the multimodal model, which implemented input from the combined ECG and chest X-ray data, the accuracy was significantly improved. Deep learning with a combination of ECG and chest X-ray data could effectively identify the AP location, which may be a novel deep learning model for a multimodal model.

Authors

  • Makoto Nishimori
    Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Hospital, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe, Japan.
  • Kunihiko Kiuchi
    Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Hospital, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe, Japan. kiuchi@med.kobe-u.ac.jp.
  • Kunihiro Nishimura
    Department of Statistics and Data Analysis, Center for Cerebral and Cardiovascular Disease Information, National Cerebral and Cardiovascular Center, 6-1 Kishibeshinmachi, Suita, Osaka 564-8565, Japan. Electronic address: knishimu@ncvc.go.jp.
  • Kengo Kusano
    Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita, Japan.
  • Akihiro Yoshida
    Kita-Harima Medical Center, Ono, Japan.
  • Kazumasa Adachi
    Akashi Medical Center, Akashi, Japan.
  • Yasutaka Hirayama
    Akashi Medical Center, Akashi, Japan.
  • Yuichiro Miyazaki
    Akashi Medical Center, Akashi, Japan.
  • Ryudo Fujiwara
    Saiseikai Nakatsu Hospital, Osaka, Japan.
  • Philipp Sommer
    Clinic of Electrophysiology, Heart and Diabetes Center NRW, University Hospital of Ruhr-University Bochum, Bochum, Germany.
  • Mustapha El Hamriti
    Clinic of Electrophysiology, Heart and Diabetes Center NRW, University Hospital of Ruhr-University Bochum, Bochum, Germany.
  • Hiroshi Imada
    Ako City Hospital, Ako, Japan.
  • Makoto Takemoto
    Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Hospital, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe, Japan.
  • Mitsuru Takami
    Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Hospital, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe, Japan.
  • Masakazu Shinohara
    Division of Epidemiology, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Ryuji Toh
    Division of Evidence-Based Labolatory Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
  • Koji Fukuzawa
    Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Hospital, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe, Japan.
  • Ken-Ichi Hirata
    Division of Cardiovascular Medicine, Department of Internal Medicine, Kobe University Hospital, 7-5-2, Kusunoki-Cho, Chuo-Ku, Kobe, Japan.